A chimaeric plant virus vaccine protects mice against a bacterial infection

被引:48
作者
Brennan, FR
Gilleland, LB
Staczek, J
Bendig, MM
Hamilton, WDO [1 ]
Gilleland, HE
机构
[1] Axis Genet PLC, Cambridge CB2 4AZ, England
[2] Louisiana State Univ, Med Ctr, Sch Med, Dept Immunol & Microbiol, Shreveport, LA 71130 USA
来源
MICROBIOLOGY-SGM | 1999年 / 145卷
关键词
cowpea mosaic virus; chimaeric virus particle; Pseudomonas aeruginosa; outer-membrane protein F; vaccine;
D O I
10.1099/13500872-145-8-2061
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The plant virus cowpea mosaic virus (CPMV) is an efficient carrier of foreign peptides for the generation of strong humoral immune responses. Peptides derived from both viruses and bacteria are strongly immunogenic when displayed on the surface of CPMV and elicit high titres of peptide-specific antibody. However, the protective effects of antibodies generated using bacterial epitopes in this system have yet to be demonstrated. In this study the ability of chimaeric virus particles (CVPs) to afford protection against bacterial infection was assessed. Immunization of outbred mice with CPMV expressing a peptide derived from outer-membrane protein F of Pseudomonas aeruginosa (CPMV-PAE5) generated high titres of P. aeruginosa-specific IgG that opsonized the bacteria for phagocytosis by human neutrophils and afforded protection upon challenge with two different immunotypes of P. aeruginosa in a model of chronic pulmonary infection. When examined 8 d after challenge, CVP-immunized mice had fewer severe lung lesions and fewer bacteria in their lungs compared to mice immunized with wild-type virus. Different levels of protection were seen with CPMV-PAE5 when Freund's or alum adjuvants were used. These studies highlight the ability of CVPs to generate protective immunity against infectious disease agents.
引用
收藏
页码:2061 / 2067
页数:7
相关论文
共 38 条
[1]   WHOLE-CELL ELISA FOR TYPING NEISSERIA-MENINGITIDIS WITH MONOCLONAL-ANTIBODIES [J].
ABDILLAHI, H ;
POOLMAN, JT .
FEMS MICROBIOLOGY LETTERS, 1987, 48 (03) :367-371
[2]   THE EXPRESSION OF HYBRID HIV-TY VIRUS-LIKE PARTICLES IN YEAST [J].
ADAMS, SE ;
DAWSON, KM ;
GULL, K ;
KINGSMAN, SM ;
KINGSMAN, AJ .
NATURE, 1987, 329 (6134) :68-70
[3]   OXIDATIVE REDUCTIVE CONJUGATION OF MANNAN TO ANTIGEN SELECTS FOR T-1 OR T-2 IMMUNE-RESPONSES [J].
APOSTOLOPOULOS, V ;
PIETERSZ, GA ;
LOVELAND, BE ;
SANDRIN, MS ;
MCKENZIE, IFC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (22) :10128-10132
[4]   Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice [J].
Ball, JM ;
Hardy, ME ;
Atmar, RL ;
Conner, ME ;
Estes, MK .
JOURNAL OF VIROLOGY, 1998, 72 (02) :1345-1353
[5]   Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed an a plant virus [J].
Brennan, FR ;
Jones, TD ;
Gilleland, LB ;
Bellaby, T ;
Xu, F ;
North, PC ;
Thompson, A ;
Staczek, J ;
Lin, T ;
Johnson, JE ;
Hamilton, WDO ;
Gilleland, HE .
MICROBIOLOGY-SGM, 1999, 145 :211-220
[6]   Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice [J].
Brennan, FR ;
Bellaby, T ;
Helliwell, SM ;
Jones, TD ;
Kamstrup, S ;
Dalsgaard, K ;
Flock, JI ;
Hamilton, WDO .
JOURNAL OF VIROLOGY, 1999, 73 (02) :930-938
[7]   The neutralizing antibody response against a conserved region of human immunodeficiency virus type 1 gp41 (amino acid residues 731-752) is uniquely directed against a conformational epitope [J].
Buratti, E ;
McLain, L ;
Tisminetzky, S ;
Cleveland, SM ;
Dimmock, NJ ;
Baralle, FE .
JOURNAL OF GENERAL VIROLOGY, 1998, 79 :2709-2716
[8]   PSEUDOMONAS-AERUGINOSA INFECTIONS IN PATIENTS WITH CYSTIC-FIBROSIS - NEW IMMUNOMODULATORY STRATEGIES [J].
BURET, A .
CLINICAL IMMUNOTHERAPEUTICS, 1994, 2 (04) :261-277
[9]   MUCOSAL AND SYSTEMIC IMMUNIZATIONS WITH KILLED PSEUDOMONAS-AERUGINOSA PROTECT AGAINST ACUTE RESPIRATORY-INFECTION IN RATS [J].
CRIPPS, AW ;
DUNKLEY, ML ;
CLANCY, RL .
INFECTION AND IMMUNITY, 1994, 62 (04) :1427-1436
[10]   Plant-derived vaccine protects target animals against a viral disease [J].
Dalsgaard, K ;
Uttenthal, A ;
Jones, TD ;
Xu, F ;
Merryweather, A ;
Hamilton, WDO ;
Langeveld, JPM ;
Boshuizen, RS ;
Kamstrup, S ;
Lomonossoff, GP ;
Porta, C ;
Vela, C ;
Casal, JI ;
Meloen, RH ;
Rodgers, PB .
NATURE BIOTECHNOLOGY, 1997, 15 (03) :248-252